You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The point-of-care system is designed to measure glycated hemoglobin levels in whole blood for use in the monitoring and management of diabetes.
Emergency testing related to the SARS-CoV-2 pandemic strongly increased, but routine testing declined due to fewer regular health checks.
CE marking of PromarkerD Hub complements the CE mark that the mass spectrometry version of the test received in November.
The company's Accu-Check SugarView app determines blood glucose ranges without a blood glucose meter by taking photos with a smartphone camera.
While the Lab 2.0 vision is still in its early days, a number of outfits around the country are providing examples of how it might be implemented.
The grant will support the development of a high-throughput method to extract and test dried blood samples collected by patients at home.
The Finnish biotechnology firm also announced plans to raise up to €80 million in the coming year.
The firm said that a new R&D plant will enable it to develop non-core testing applications that allow it to enter new markets, such as veterinary diagnostics.
The firm is conducting clinical trials in preparation for applying for FDA clearance to market its POC instrument and first assay in the first quarter of next year.
The researchers said the test performed well in distinguishing patients with or without complications and proved itself better than frequently used clinical variables.